WORLD TECH

Global Biotech News

Coverage of biotechnology follows what the science produces and what industry does with it — therapies, platforms, funding and the regulatory decisions that move products toward or away from use. Reporting here separates a trial from an approval.

AI Drug Firm Raises $5bn to Push Candidates

AI Drug Firm Raises $5bn to Push Candidates

Isomorphic Labs, a DeepMind spinout, plans to advance AI-designed cancer and immune treatments toward clinical trials; the candidates remain pre-clinical.

Live Poll

Do you trust AI to help develop safe new medicines?


Recent news


More in Biotech

Statewide reporting centres on clinical trial results and their methodologies, gene therapy and CRISPR applications, genomics platforms, biotech funding rounds, and the regulatory decisions that determine what reaches patients. It explains what a trial result actually shows and what further work it requires. Regulatory timelines shape the sector more than any single scientific milestone because they determine when a therapy becomes a product. Acquisition activity receives sustained attention since it restructures which programs advance.